{"id":1866,"date":"2016-02-26T16:08:00","date_gmt":"2016-02-26T16:08:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/on-grindeks-results-in-2015\/"},"modified":"2022-06-30T16:11:50","modified_gmt":"2022-06-30T16:11:50","slug":"on-grindeks-results-in-2015","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/on-grindeks-results-in-2015\/","title":{"rendered":"Par Grindeks rezult\u0101tiem 2015. gad\u0101"},"content":{"rendered":"\n

\u0160odien, 26. febru\u0101r\u012b, akciju sabiedr\u012bbas Grindeks \u201eNASDAQ Riga\u201d iesniegtie 2015. gada nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2015. gad\u0101 bija 82,9 milj. eiro, kas ir par 5,6 milj. eiro vai par 6,3% maz\u0101k nek\u0101 2014. gad\u0101. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, 2015. gad\u0101 bija 1,0 milj. eiro, sal\u012bdzinot ar 2014. gadu, kuru Koncerns pabeidza ar 2,5 milj. eiro zaud\u0113jumiem.<\/p>\n\n\n\n

Bruto pe\u013c\u0146as rentabilit\u0101te 2015. gad\u0101 bija 44,4%, savuk\u0101rt t\u012br\u0101s pe\u013c\u0146as rentabilit\u0101te bija 1,2%. 2015. gad\u0101 Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 70 pasaules valst\u012bm kopum\u0101 par 74,4 milj. eiro, kas ir par 8,5 milj. eiro vai par 10,2% maz\u0101k nek\u0101 2014. gad\u0101.<\/p>\n\n\n\n

Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2015. gad\u0101 bija 74,9 milj. eiro un ir samazin\u0101jies, sal\u012bdzinot ar iepriek\u0161\u0113jo gadu, par 4,1 milj. eiro vai 5,2%. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2015. gad\u0101 sasniedza 41,5 milj. eiro, kas ir par 19,0 milj. eiro vai 31,4% maz\u0101k nek\u0101 2014. gad\u0101. Sal\u012bdzinot ar iepriek\u0161\u0113jo gadu, iev\u0113rojam\u0101kais p\u0101rdo\u0161anas apjoma pieaugums sasniegts Gruzij\u0101 par 25% un Turkmenist\u0101n\u0101 par 37%.<\/p>\n\n\n\n

Pateicoties biznesa diversifik\u0101cijas strat\u0113\u0123ijai un darb\u012bbas att\u012bst\u012bbai jaunos tirgos, p\u0101rdo\u0161anas apjoms Baltijas un cit\u0101s valst\u012bs 2015. gad\u0101 sasniedza 33,4 milj. eiro, kas ir par 14,9 milj. eiro vai 1,8 reizes vair\u0101k nek\u0101 2014. gad\u0101. P\u0101rdo\u0161anas apjoms N\u012bderland\u0113, sal\u012bdzinot ar 2014. gadu, ir palielin\u0101jies 14,1 reizes, Norv\u0113\u0123ij\u0101 \u2013 3,3 reizes, savuk\u0101rt Vjetnam\u0101 palielin\u0101jies 2,2 reizes un Polij\u0101 \u2013 1,8 reizes. 2015. gad\u0101 Grindeks uzs\u0101ka gatavo z\u0101\u013cu formu eksportu uz Franciju, sasniedzot 0,5 milj. eiro p\u0101rdo\u0161anas apjomu, k\u0101 ar\u012b uz Kan\u0101du, sasniedzot 0,3 milj. eiro p\u0101rdo\u0161anas apjomu. 2015. gad\u0101 Latvij\u0101 p\u0101rdo\u0161anas apjoms sasniedza 6,6 milj. eiro, kas, sal\u012bdzinot ar iepriek\u0161\u0113jo gadu, ir palielin\u0101jies par 1,9 milj. eiro vai par 41,6%.<\/p>\n\n\n\n

2015. gad\u0101 Grindeks papildin\u0101ja produktu kl\u0101stu un ieviesa UDHS (ursodeoksiholsk\u0101be) gatavo z\u0101\u013cu formu (kapsulu), k\u0101 ar\u012b uzs\u0101ka \u0161\u012b produkta ra\u017eo\u0161anu un eksportu uz div\u0101m valst\u012bm \u2013 Krieviju un Gruziju. T\u0101d\u0113j\u0101di Grindeks ir papla\u0161in\u0101jis savu pied\u0101v\u0101jumu gastroenter\u0101l\u0101 trakta un vielmai\u0146as z\u0101\u013cu terapeitiskaj\u0101 grup\u0101. Grindeks ir papla\u0161in\u0101jis ar\u012b uztura bag\u0101tin\u0101t\u0101ju kl\u0101stu un ieviesis divus jaunus produktus \u2013 jaun\u0101k\u0101s paaudzes piensk\u0101bo un bifidobakt\u0113riju kompleksu Lactobex\u00ae<\/small> Strong un Herbastress\u00ae<\/small> miegam. Abi produkti tiek izplat\u012bti Baltijas valst\u012bs.<\/p>\n\n\n\n

2015. gad\u0101 akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 7,2 milj. eiro, kas ir par 1,8 milj. eiro vai 20,3% maz\u0101k nek\u0101 2014. gad\u0101. Galvenie Grindeks akt\u012bvo farmaceitisko vielu eksporta tirgi ir Eiropas Savien\u012bbas valstis, ASV, Kan\u0101da, Indija un Jap\u0101na. Grindeks piepras\u012bt\u0101k\u0101s akt\u012bv\u0101s farmaceitisk\u0101s vielas 2015. gad\u0101 bija oksitoc\u012bns, zopiklons, ftoraf\u016brs, detomid\u012bns un ksilaz\u012bns.<\/p>\n\n\n\n

AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis: \u201eGlob\u0101l\u0101 ekonomisk\u0101 un politisk\u0101 situ\u0101cija turpina b\u016bt main\u012bga un bie\u017ei vien pat gr\u016bti prognoz\u0113jama. Lai konkur\u0113tu pasaules farm\u0101cijas tirg\u016b, tagad v\u0113l vair\u0101k nek\u0101 agr\u0101k ir j\u0101izmanto savas stipr\u0101s puses, j\u0101m\u0101k p\u0101rorient\u0113ties, nov\u0113rt\u0113t visus apst\u0101k\u013cus un piel\u0101got savu darb\u012bbu jauniem nosac\u012bjumiem. Lai mazin\u0101tu biznesa riskus savos tradicion\u0101lajos tirgos, \u0161ogad ap\u0146\u0113m\u012bgi izmantoj\u0101m savu potenci\u0101lu citos tirgos. \u0160obr\u012bd eksport\u0113jam jau uz 70 pasaules valst\u012bm, un 2016. gad\u0101 strat\u0113\u0123iski un m\u0113r\u0137tiec\u012bgi koncentr\u0113simies uz darb\u012bbas att\u012bst\u012bbu Eiropas Savien\u012bb\u0101 un Dienvidaustrum\u0101zijas valst\u012bs. \u0160ajos tirgos p\u0101rdo\u0161anas apjomu pl\u0101nojam audz\u0113t par 30%. Izstr\u0101d\u0113 ir jauni produkti, ir uzs\u0101kta virkne re\u0123istr\u0101cijas proced\u016bru daudz\u0101s pasaules valst\u012bs \u2013 tas v\u0113l vair\u0101k stiprin\u0101s Grindeks poz\u012bcijas.\u201d<\/p>\n\n\n\n

<\/a>Grindeks rezult\u0101ti 2015 (473 KB)<\/a><\/p>\n\n\n\n

<\/a>Infografika 2015 (418 KB)<\/a><\/p>\n\n\n\n

<\/a>Grindeks prezent\u0101cija 2015 (2 MB)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u0160odien, 26. febru\u0101r\u012b, akciju sabiedr\u012bbas Grindeks \u201eNASDAQ Riga\u201d iesniegtie 2015. gada nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2015. gad\u0101 bija 82,9 milj. eiro,…<\/p>\n","protected":false},"author":3,"featured_media":1863,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/1866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=1866"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/1866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/1863"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=1866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=1866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=1866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}